| Autor: |
Elmar Wolf, Rupert Öllinger, Jürgen Ruland, Gaurav Jain, Stefan Burdach, Gunther Richter, Andreas Petry, Michaela C. Baldauf, Uwe Thiel, Carolin Prexler, Poul H. Sorensen, Erik Hameister, Agnes Görlach, Julia Hofstetter, Maxim Barenboim, Thomas G. P. Grunewald, Juliane Schmäh, Busheng Xue, Davide G. Franchina, Rebeca Alba Rubio, Roland Rad, Gunnar Cario, Alexandra Sipol, Dirk Brenner |
| Rok vydání: |
2020 |
| Předmět: |
|
| Popis: |
Cancer cells are in most instances characterized by rapid proliferation and uncontrolled cell division. Hence, they must adapt to proliferation-induced metabolic stress through intrinsic or acquired anti-metabolic stress responses to maintain homeostasis and survival. One mechanism to achieve this is to reprogram gene expression in a metabolism-dependent manner. MondoA (also known as MLXIP), a member of the MYC interactome, has been described as an example of such a metabolic sensor. However, the role of MondoA in malignancy is not fully understood and the underlying mechanism in metabolic responses remains elusive. By assessing patient data sets we found that MondoA overexpression is associated with a worse survival in pediatric common acute lymphoblastic leukemia (cALL). Using CRISPR/Cas9 and RNA interference approaches, we observed that MondoA depletion reduces transformational capacity of cALL cells in vitro and dramatically inhibits malignant potential in an in vivo mouse model. Interestingly, reduced expression of MondoA in patient data sets correlated with enrichment in metabolic pathways. The loss of MondoA correlated with increased tricarboxylic acid (TCA) cycle activity. Mechanistically, MondoA senses metabolic stress in cALL cells by restricting oxidative phosphorylation through reduced PDH activity. Glutamine starvation conditions greatly enhance this effect and highlight the inability to mitigate metabolic stress upon loss of MondoA in cALL. Our findings give a novel insight into the function of MondoA in pediatric cALL and support the notion that MondoA inhibition in this entity offers a therapeutic opportunity and should be further explored.Key PointsMondoA maintains aggressiveness and leukemic burden in common ALL, modulating metabolic stress response. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
